Chile, Belarus Poised to Join the Growing List of Global South Countries That Will Produce Chinese COVID-19 Vaccines

Source: Bridge Consulting

China’s drive to build manufacturing capacity for its COVID vaccines in countries across the Global South is poised to expand. Talks are now underway to build so-called “fill and finish” facilities in both Belarus and Chile.

Chinese pharmaceutical companies already have 14 production agreements in place, predominantly in Asia, Africa, and the Americas, according to data from Bridge Consulting in Beijing.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

OR

Already a subscriber? Log in Click Here to Learn More
by Eric Olander

Most Read

1
Developing Countries’ Debt Servicing Costs to China Are Significant, but Nowhere Near as Much as Other Creditors
2 Chinese Military Fans Discuss Why Indonesia Bought Rafale Instead of J-10C
3
China, U.S. Ink Rare Earth Deal; More Trade Pacts Coming
4
Chinese Cargo Planes Secretly Ferrying Supplies to Iran, Claim Online Sleuths
5
Six Million Donkeys Slaughtered for Chinese Medicine: Charity
6
Rubio to Welcome Asian ‘Quad’ Back to Washington

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

More about CGSP